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bioelectrics. 
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ABSTRACT 
The majority of cystic fibrosis patients produce a mutant form of CFTR (ΔF508) 
which has been shown to be mislocalised in both humans and mice. G480C, 
another clinically "severe" mutation, has also been demonstrated to be defective 
in its intracellular processing, but when allowed to traffic in Xenopus oocytes 
showed similar channel characteristics to that of wildtype CFTR. We have 
replicated the G480C mutation in the murine Cftr gene using the "hit and run" 
double recombination procedure. As expected, the G480C cystic fibrosis mouse 
model expresses the G480C mutant transcript at a level comparable to that of 
wild type Cftr. The homozygous mutant mice were fertile, had normal survival, 
weight, tooth colour and no evidence of caecal blockage, despite mild goblet cell 
hypertrophy in the intestine. Analysis of the mutant protein revealed that the 
majority of G480C CFTR was abnormally processed and no G480C CFTR-
specific immunostaining in the apical membranes of intestinal cells was detected. 
The bioelectric phenotype of these mice revealed organ specific 
electrophysiological effects. In contrast to ΔF508 "hit and run" homozygotes, the 
classic defect of forskolin-induced chloride ion transport is not replicated in the 
caecum, but the response to low chloride in the nose is clearly defective in the 
G480C mutant animals. The mild phenotype of these G480C mutant animals 
combined with the defective chloride transport in the nose uniquely provides a 
valuable resource to test novel pharmacological agents aimed at improving 
trafficking and correcting the electrophysiological defect in the respiratory tract. 
INTRODUCTION 
Cystic fibrosis (CF) is a fatal autosomal recessive genetic disease 
characterised by abnormal epithelial ion transport. The mutated gene responsible 
is the cystic fibrosis transmembrane conductance regulator (CFTR) gene 
encoding a protein which functions among other things as an epithelial cAMP-
regulated Cl- ion channel 1. Many hundreds of mutations have been described in 
CF patients but the most common mutation, is caused by deletion of a 
phenylalanine at position 508 (ΔF508)2. This mutation causes misfolding of the 
protein, incomplete glycosylation and prevents correct trafficking of the protein to 
the apical plasma membrane3. 
 In humans ΔF508 accounts for approximately 70% of all mutant CF 
alleles and is considered "severe" with respect to cystic fibrosis phenotype. Other 
"severe" mutations have been described and G480C is one where an amino acid 
substitution occurs in exon 10 of CFTR3. Both G480C and ΔF508 mutations 
show a primary defect in protein processing and trafficking, such that mutant 
protein is retained and degraded in the endoplasmic reticulum, resulting in a 
severe reduction at the plasma membrane4;5;6. When expressed in Xenopus 
oocytes (where the transport block can be overcome), the G480C protein has an 
apical plasma membrane Cl- channel activity identical to that of wild type CFTR6.  
Contradictory reports exist for ΔF508 function at the apical membrane, some 
suggesting reduced function and others suggesting normal function 7-9. 
We created mutant mice that carry the G480C mutation by gene targeting 
using the “hit and run” technique 10;11. These mice are comparable to the 
Cftrtm1Eur mice where the "hit and run" technique was used to introduce the ΔF508 
mutation into the mouse. 12. In both these Cftr mutant mice the only alteration in 
the Cftr gene is the introduced mutation, and transcription of the mutant allele 
does not deviate from wild type levels13. This is in contrast to replacement mouse 
models, where the gene targeting event introduces plasmid sequences into an 
intron and the transcription of the mutant allele is reduced14,15.  Thus for example, 
in the Cftrtm2Cam ΔF508 mice the level of Cftr mRNA is approximately 15% of 
wildtype levels14. In such mutant mice (eg. the ΔF508 Cftrtm2Cam and the G551D 
Cftrtm1G551D mice), it is therefore difficult to assess whether the phenotype is due 
to the precise mutation or principally related to a reduction in the level of the 
transcript. 
 The Cftrtm1Eur mice, where ΔF508 Cftr transcript levels are normal, 
possess a small, residual forskolin response in the gut 12, not evident in the 
intestine of the "null" or other ΔF508 mutant mice. In the nasal tissue these 
ΔF508 mutant mice cannot be distinguished from littermates on the basis of their 
low chloride response 12. The “null” and low level transcript ΔF508 mice die 
perinatally or at weaning due to intestinal blockage but do display a clear defect 
in their nasal bioelectrics. In this study an accurate mouse model of the G480C 
mutation was used to assess the phenotype of another “severe” cystic fibrosis 
mutation in vivo and to clarify the organ-specific consequences of a mistrafficking 
mutant.  
RESULTS  
Generation of Cftrtm2Hgu mice which carry the G480C mutation 
ES cells modified at the Cftr locus to possess the G480C mutation in exon 
10 by ‘Hit and Run’ gene targeting have been previously described 11. 4 ES cell 
clones modified to possess the G480C mutation which had normal karyotypes 
were used for blastocystst injections. Germline transmission of the mutation was 
detected by genotyping agouti offspring from mating the chimaeric males to 
C57Bl/6 females and was observed in 2 independent clones, with all mice used 
in this study originating from a single transmitting chimaeric founder animal. 
Homozygous G480C mutant mice are designated Cftrtm2Hgu following the Mouse 
Nomenclature Committee guidelines. A novel NsiI restriction enzyme site was 
created at the site of the G480C mutation (Figure 1A) and restriction enzyme 
digestion verified the faithful replacement of the wild type exon 10 with the 
mutant exon 10 (Figure 1 B, C, D). PCR amplification of exon 10 and digestion 
with NsiI differentiated the enzyme resistant wildtype band from the G480C 
containing band, which can be digested with the enzyme (Figure1E).  
G480C mutant mice express the mutant allele at wild-type levels 
Both male and female mice heterozygous for the G480C allele were 
included in the study and a range of tissues investigated. The ΔF508 mice 
generated by replacement gene targeting (Cftrtm2Cam) show differences in the 
extent of allele bias between tissues14.  Cftr mRNA expression was demonstrated 
by RT-PCR between exons 9 and 10 and was observed in all of the tissues 
investigated, (lung, colon, jejunum, ileum and testis).  Samples were taken during 
the linear range of the PCR amplification as determined by real-time 
luminescence assay (Methods), to reduce heteroduplex formation.  G480C 
products were distinguished from wild type by the presence of the novel NsiI 
restriction site polymorphism engineered adjacent to the missense change. 
Densitometric quantitation of PCR products after NsiI digestion indicated 
approximately equal ratios of each allele in the ileum, jejunum, testis and lungs 
(Figure 2 and Table 1), except in one lung sample which appeared to undergone 
degradation following digestion. These results indicate that the modified allele 
was expressed at the same level as the wild type allele and therefore the 
presence of the G480C mutation has no effect on the level of expression. 
G480C CFTR is incompletely processed 
Analysis of CFTR processing in isolated jejunal enterocytes of wild-type 
mice by Western blotting demonstrated a normal pattern of CFTR isoforms with 
the core-glycosylated isoform of CFTR (band B) in the ER, and the mature, fully-
glycosylated isoform (band C) in the plasma membrane. Band B was identified 
only in the crude membrane preparation (Fig. 3, lane 1) consisting of a mixture of 
ER, Golgi and plasma membranes, whereas band C was additionally detected 
(and approximately two-fold enriched) in the brush border membrane vesicle 
preparations (BBMV) (Fig.3, lane 3) consisting of virtually pure apical 
membranes. In contrast, intestinal epithelium from homozygous G480C mice 
showed a normal intensity of the B-band of CFTR in the crude jejunal membrane 
fraction (Fig.3, lane 2), but a strongly reduced intensity of the C-band (measured 
as 8% (+/-2) n=4, residual CFTR compared to wildtype as determined by dilution 
calibrated scanning of the bioluminescence) in the BBMV (Fig.3, lanes 2 and 4). 
This outcome clearly demonstrates that the G480C CFTR mutant protein is 
retained in the ER of the enterocytes in vivo and that only a very small fraction is 
able to escape the quality control mechanism in the ER and reach the cell 
surface. 
Immunocytochemical detection of CFTR in the jejunum from wild-type 
mice using the R3195 antibody, (in keeping with previous findings 13, showed 
intensive staining of the apical region of all crypts (Fig. 4A). In addition, due to 
the improved sensitivity of CFTR staining in microwave-treated paraffin sections 
as compared to cryosections, CFTR immunoreactivity was also prominent in the 
brush border membrane of lower- and mid-villus cells. In contrast, CFTR 
expression in crypts and villi from homozygous G480C mutant mice remained 
below the detection level of the immunocytochemical technique (Fig. 4B). This 
finding confirms the results of the Western blotting shown in Fig. 3 and is in line 
with the concept of a processing defect affecting the maturation of G480C-CFTR 
in both the crypt and villus compartments. 
Phenotype of the cystic fibrosis mutant mice homozygous for the G480C 
mutation 
Figure 5 demonstrates that genotypes of the litters produced from matings 
between G480C heterozygous mice did not deviate from the expected Mendelian 
ratio of wild type:heterozygotes: homozygotes of 1:2:1 and no reduction in the 
number of homozygotes was observed. This was true in the offspring from 
mating heterozygotes from the outbred 129/Ola/C57Bl/6N background and also 
from mating heterozygotes from a 4th generation of backcross matings to 
C57Bl/6N mice. Further, homozygous G480C mice did not show any increased 
mortality over wild type animals (pre or post weaning) over an 18 month period.  
The weight (at weaning) of the three genotypes did not differ significantly (figure 
5), and both males and females were fertile (data not shown).  
 Histological analysis of intestinal sections demonstrated focal hypertrophy 
of goblet cells in the G480C homozygous mutant mice. Sections from the G480C 
mutants could easily be distinguished from wild type by this criterium alone 
(figure 4). This hypertrophy is however much less severe than that observed in 
the "null" (Cftrtm1Unc or Cftrtm1Cam 16;17 ) mice and is similar to that observed in the 
Cftrtm1Eur ΔF508 mice12. In addition we saw no evidence (n=20 mice) of  dramatic 
distention of crypts in the small intestine, blockage, nor any evidence of an 
abnormal coiled, worm-like caecum impacted with sticky fecal material which is 
described as the only obvious intestinal abnormality in the Cftrtm1Unc mice   
sacrificed while apparently still healthy16.  
The Cftrtm1Unc "null" mice and Cftrtm1Eur ΔF508 "hit and run" mice display 
white teeth as a result of decreased enamel mineral content and increased 
magnesium (18 and H de J unpublished data). Both these strains of mice can be 
genotyped purely on the basis of their white tooth colour. The incisor teeth of the 
G480C mutant mice however were not abnormally white (data not shown). 
Electrophysiological characteristics of G480C CFTR mice 
The reduced chloride permeability of the epithelium due to CFTR dysfunction, 
causes typical abnormalities in the ion transport of different epithelia in both CF 
individuals and Cftr mutant mice. The G480C cystic fibrosis mice do not suffer 
from the intestinal blockage (the first signs of which are located in  the caecum) 
that is seen in mice with a complete disruption of Cftr expression, so we 
examined the electrophysological profile of these animals in the intestine. 
 In the caecum, Ussing chamber measurements revealed that the initial 
baseline Isc (short circuit current) was significantly (p=0.0001) reduced in the 
G480C homozygous mutants compared to controls (Fig 6A). However the 
response to forskolin, which activates CFTR through an increase in cAMP, was 
not significantly different between wild type and mutant animals. Carbachol 
(which stimulates Ca2+ mediated chloride transport) probably also via CFTR in 
the intestine, was however significantly (p=0.01) reduced compared to wildtypes. 
In the jejunum (Figure 6B) however, the baseline Isc was not significantly 
different between the mutants and wildtypes, but the forskolin response was 
significantly (p=<0.01) different. The carbachol response, as in the caecum, was 
significantly reduced compared to littermates (p<0.01).  
Several studies have demonstrated that in the intestine of rodents, the 
baseline and stimulated secretions are independent when the stimulation is 
made with forskolin. Naturally cAMP levels may be elevated via prostaglandin 
increase. These studies however show that the forskolin- and prostaglandin-
mediated pathways are independent in as far as normal forskolin-mediated 
secretion can be achieved following prostaglandin-mediated secretion 19 20;21. In 
addition we can demonstrate (H.de J. unpublished results) that the basal short 
circuit current in the murine intestine was not affected by 10-5M indomethacin (a 
potent inhibitor of prostaglandin synthesis) and is therefore not 
prostaglandin/cAMP mediated. We are therefore confident that the responses  
generated in this study by forskolin are independent of any prostaglandin-
mediated baseline secretion in the jejunum and caecum.  
We also examined the nasal biolelectrics of these mice (figure 6C) and in 
common with all other described CFTR mutant mice22, the baseline was 
significantly (p=<0.001) raised. The response to a low chloride gradient was 
significantly (p=0.0001) reduced in the G480C mutant animals, in contrast to the 
normal response reported in the Cftrtm1Eur ΔF508 mouse. 
DISCUSSION 
The mutant mice we present here mimic human CF individuals with the 
“severe” G480C mutation. The G480C mutant protein was detected in a 
pancreatic insufficient African-American CF patient 6. Western blot analysis and 
immunofluorescent analysis revealed that even when overexpressed in 293T 
cells, no fully glycosylated nor apically localised protein was detectable. This 
suggested that the G480C protein was similar to the ΔF508 protein and subject 
to defective intracellular processing. We demonstrate that when replicated in the 
mouse, the G480C mutant CFTR is mislocalised and the defect in chloride ion 
transport characteristic of CF varies between tissues and is present in the nose 
and jejunum but absent from the caecum with no evidence of fatal gut blockage.  
G480C mutant mice express normal levels of the mutant allele. 
The “hit and run” procedure used to generate these mice results in the 
only genomic alteration being at the site of the mutation. It follows that the 
message levels of the mutant allele will be equivalent to the wild type allele. In 
ΔF508 / wild type heterozygous humans, mRNA of both alleles is present at an 
equal ratio 23. Mice created by gene targeting for the common ΔF508 mutation by 
replacement gene targeting14, used a vector which included a reverse orientation 
HPRT mini-gene selection cassette in intron 10 along with the ΔF508 mutation in 
exon 10.  The derived heterozygote mice were determined to have a Cftr 
expression bias at the mRNA level in favor of the wild type allele over the 
engineered ΔF508 allele. No reasons for this bias were investigated or 
considered in the original paper, but the most likely possibility is interference from 
the transcription of HPRT in the reverse orientation, from within intron 10; 
although binding of transcription repressors, chromatin modification, methylation 
and RNA processing differences are all possibilities. These Cftrtm2Cam ΔF508 
mutant mice have a very low level of mutant transcript and a phenotype very 
similar to the “null” Cftr mutant mice where the vast majority die perinatally or 
around weaning from intestinal blockage. The Cftrtm1Kth ΔF508 mice were also 
made by replacement gene targeting and again have a high level of early death 
from intestinal blockage24. The “hit and run” (Cftrtm1Eur) ΔF508 mutant mouse in 
contrast has a normal level of mutant transcript and although it displays evidence 
of growth retardation at weaning 12, it does not demonstrate a phenotype of death 
from gut blockage. In contrast to the ΔF508 mice generated by replacement gene 
targeting, the Cftrtm1Eu ΔF508 ‘hit and run’ mice and the Cftrtm2Hgu G480C ‘hit and 
run’ mice generated here both express normal levels of the mutant allele. 
G480C mutant protein is mislocalised 
The majority of G480C CFTR when subjected to Western blot analysis is 
clearly mislocalised in vivo in the mouse intestine. However a low (approximately 
8% of wild type) level of mature band C is evident in the BBMV preparations. 
This outcome clearly suggests that the majority of G480C-CFTR mutant protein 
is retained in the ER of the enterocytes in vivo but that a significant fraction is 
able to escape the quality control mechanism in the ER and travel to the cell 
surface. In jejunal BBMV samples from ΔF508 Cftrtm1Eur mice the residual level of 
mature protein was estimated at 3%(+/-1) of wild type, (HdJ, RW unpublished 
results). This suggests that the G480C processing defect in the intestine is 
slightly less severe than that of the ΔF508 mutant in vivo. It should be noted that 
although 8% of normal levels of mature G480C was detectable in Western blot 
analysis of BBMV, only cytoplasmically localized protein could be detected by 
immunohistochemistry. 
The phenotype of the Cftrtm2Hgu G480C mutant mice is mild 
The Cftrtm2Hgu G480C mutant mice do not demonstrate a phenotype of 
death from gut blockage and unlike the ΔF508 Cftrtm1Eurmice do not even display 
any evidence of growth retardation at weaning. The histology of the G480C 
intestine is not severely abnormal unlike the Cftrtm1Unc “null” mice, which display 
extensive goblet cell hyperproliferation, increased mucus accumulation and 
luminal obstruction. The ΔF508 mice display focal hypertrophy of goblet cells in 
the crypts of the small intestine. The G480C mice (as is evident in fig 4), also do 
not have any gross abnormalities but do display a mild focal hypertrophy of 
goblet cells comparable to the data reported for the ΔF508 Cftrtm1Eur 
homozygotes.  
The classic CF chloride transport defect is not present in the caecum and 
may account for the lack of intestinal blockage. 
The G480C mutant mice do not show a defect in their forskolin response 
in the caecum, although baseline and carbachol response are altered compared 
to wild type. The ΔF508 “hit and run” mutant mice in contrast to the G480C mice 
have a significant but markedly reduced (by 85%) forskolin activated chloride ion 
conductance in the caecum compared to wild type13. In fact all previously 
reported CF mutant mice that show a reduced incidence of death from intestinal 
obstruction (Cftrtm1Hgu,Cftrtm1Eur, Cftrtm1G551D ), also show an increased caecal 
cAMP response compared to Cftr mutant mice with a high death rate from 
intestinal blockage 22. The caecum is the region of the gut where most of the 
intestinal blockage occurs in “null” Cftr mice so a normal forskolin response (but 
not baseline or Ca2+ agonist response) in this tissue is likely to be important in 
ameliorating this phenotype.  
Variation between the bioelectric phenotypes of ΔF508 and G480C "hit 
and run" mutant mice could be explained by the effect of modifier genes of 
residual chloride secretion present in the genetic backgrounds on which the 
mutations have been bred. This is unlikely because French et al 13 and ourselves 
(data not shown) have demonstrated that the electrophysiological profiles in the 
caecum, ileum and jejunum of wild type 129 and C57Bl/6 mouse strains are not 
significantly different. In addition neither appear to have any dominant gene 
effects on the intestinal bioelectrics. Finally, the G480C mice show 100% survival 
on a mixed 129/C57Bl/6J background (same as that reported for the Cftrtm1Eur 
mice with 100% survival) and this does not alter after 4 backcrosses onto the 
C57Bl/6J background. This is the same genetic background as that reported for 
the Cftrtm1Unc "null" mice with only 20% survival, and reproduced in our animal 
house 15. 
It is probable that the normal forskolin response in the G480C mice 
compared to the abnormal response in Cftrtm1Eur ΔF508 mice is due to slightly 
more G480C (3% versus 8%) being correctly processed and reaching the apical 
membrane. However the results from Xenopus oocyte experiments using human 
CFTR mRNA, strongly suggested that this observed difference between the 
G480C and ΔF508 response to forskolin was consistent with a 
trafficking/processing defect in G480C CFTR, and an additional conductance 
defect in ΔF508 CFTR6. We doubt if this additional conductance defect is the 
case here as the ΔF508 "hit and run" mice have identical channel characteristics 
to wildtype in the gall bladder epithelia 13.  
The fact that “hit and run” ΔF508 mutant mice (Cftrtm1Eur) display runting 
but no evidence of the fatal intestinal blockage presented by “null” CF mice is in 
contrast to ΔF508 homozygous patients, who do not have reduced incidence of 
meconium ileus when compared to patients with “null” mutations. One possible 
explanation is that the G480C and ΔF508 mouse phenotype appear to be 
different to "null" mice because of differences in human/mouse physiology and 
gut architecture, and the mouse is more sensitive to small increases in CFTR 
function.  
Electrophysiological phenotype of the murine G480C mutant protein varies 
between tissues. 
An unexpected finding was the organ-specific differences in CFTR related 
electrophysiology in the mutant mice. As discussed above we suggest that a 
normal cAMP-mediated chloride secretion in the caecum is due to around 8% 
correctly localized CFTR. This agrees with our previous work 25, where we 
demonstrate, using intercrossed mutants, that a very low level of functional 
CFTR (5%) is sufficient to have a disproportionate effect on chloride ion transport 
and a major effect on phenotype (survival due to lack of intestinal obstruction). 
Interestingly the caecal baseline and Ca2+-activated chloride response remain 
abnormal despite a normal forskolin response. This implies that these aspects 
may not be key markers of intestinal blockage and in addition, that there is a 
CFTR dose-response in terms of restoration of function within an organ. These 
are important considerations when monitoring the efficacy of therapies aimed at 
amelioration of the phenotypes in CF individuals.  
In the nose of the Cftrtm2Hgu mice, in common with all other reported CF 
mice and individuals22, the baseline PD is raised indicating a defect in sodium 
absorption. The familiar defect in cAMP mediated chloride secretion was also 
observed in the nose, which is in direct contrast to the Cftrtm1Eur ΔF508 mutant 
mouse but in common with all other mutant mice including the 10% residual 
function mouse (Cftrtm1Hgu). So, the fact that the cAMP stimulated response is not 
defective in the caecum, but the nasal low chloride response is defective, again 
demonstrates inter organ differences in this "dose response". This must reflect 
either tissue specific alterations in the level of mature G480C CFTR with organ- 
specific subtle translational/post translational differences, or compensatory 
pathways altering the bioelectric phenotype. We tentatively suggest that 
correction may be more difficult in the airways as compared to the large intestine.   
 The Cftrtm2Hgu G480C mutant mouse is a valuable tool for therapy testing  
Both the defects in sodium absorption and in chloride secretion are 
evident in the nose of the G480C mutant mouse and this is widely held to be the 
mouse tissue that mimics the human respiratory tract phenotype most closely26. 
70% of CF chromosomes have the ΔF508 mutation and so the vast majority of 
CF individuals possess at least one ΔF508 allele. This makes pharmacological 
strategies aimed at improving the function of the ΔF508 mutant CFTR highly 
relevant. The three mouse models generated to date that express the ΔF508 
mutant allele either suffer a high level of intestinal blockage and death (Cftrtm2Cam, 
Cftrtm1Kth), or survive well but do not have the bioelectric defect of chloride ion 
transport in the respiratory tract. The fact that this G480C mutant mouse 
combines a mistrafficked CFTR mutation (similar to the ΔF508 CFTR) with 
normal survival means that it is an excellent in vivo model for testing drugs aimed 
at mutant CFTR relocation strategies. 
 In conclusion, the introduction of the G480C mutation into the mouse Cftr 
gene, using the "hit and run" technique mimics the human allele with normal 
levels of Cftr mRNA production. This has allowed us to demonstrate that the 
majority of the G480C mutant protein is mislocalised, but a low level of mature 
CFTR is detectable by immunoblot.  The phenotype of the mutant animals is 
extremely mild, and does not include severe gut blockage or growth retardation. 
The G480C homozygous mutant protein has different ion transport effects in 
different organs with pronounced effects on the baseline in the nose and the 
caecum. In the nose, the mutant animals have increased absorption whilst in the 
caecum reduced secretion is evident. Reduced stimulated chloride secretion has 
been found in the nose and the jejunum but a normal response was found in the 
caecum and this is most likely responsible for the lack of fatal intestinal blockage 
and normal weight of the G480C mutant mice.  
MATERIALS AND METHODS 
Gene Targeting in ES cells  
Targeting methodology is as previously described11. Screening of litters for 
transmission of the G480C allele was performed by PCR using 25 base pair 
primers used to amplify exon 10 from positions 1530-1720 in the Cftr gene 
previously described27 followed by NsiI digestion. 
Real-time RT-PCR analysis 
Cftrtm2Hgu/+ heterozygous G480C mice were sacrificed by CO2 
asphyxiation. Tissues were dissected out, washed in PBS and snap frozen in 
liquid nitrogen.  Samples were thawed, homogenized in 1ml RNAzol B 
(Biogenesis) and 100 µl chloroform added for phase extraction.  Nucleic acids 
were ethanol precipitated at 4°C, washed with 80% (v/v) ethanol and 
resuspended in 200 µl DEPC treated dH2O for 18 hours at 4°C.  Yield was 
determined spectrophotomerically after heat denaturation of 1/250 sample 
dilutions.  OD260/280 ratio of 2 was typically obtained. 1µg total cellular RNA was 
reverse transcribed in 20 µl total volume reactions containing AMV RTase 
(Boehringer Mannheim) and manufacturers recommended concentrations of 
buffer, Mg2+, dNTP, gelatin and RNase inhibitor.  Random hexanucleotides were 
used to prime synthesis.  Additional to manufacturers recommendations, a 10 
min room temperature incubation was included to allow primer annealing and 
reverse transcription was carried out at 42°C for 1hr.  Enzyme was heat killed by 
incubation at 95°C for 15 min and samples stored at -70°C.  For each reverse 
transcription reaction carried out, a reverse trancriptase negative control was 
also performed. 
Measurements of laser activated fluorescence of nucleic acid intercalated 
SYBR Green (FMC Bioproducts) were used to define a reproducible window in 
which PCR products were sufficiently abundant to be detected by Southern blot, 
but still within the exponential range of amplification.  Reactions were carried out 
in Idaho Technologies “Light Cycler”.  Thermal cycling proceeded through 95°C 
for 0 seconds (subsequent to a 30 second initial denaturation), 57°C for 0 
seconds and 74°C for 6 seconds; the rapid ramping of temperature achievable 
through the use of glass capillary tubes as reaction vessels.  Cycling was 
performed until the target window of amplification was attained. At this point the 
temperature was held at 74°C at the end of the 6 second normal extension to 
allow removal of samples which were slowly cooled to room temperature. Semi-
quantitative RT-PCR and appropriate controls were amplified using primers M9AI 
(5'-AGCAATGGTGACAGAAAACATTCC -3') and M10B (5’-
CTGCTGTAGTTGGCAAGCTTTGAC -3’).  Reagents were as recommended 
(Biogene).  AmpliTaq (Perkin Elmer) was the polymerase used. PCR products 
were electrophoretically separated at 100 V on 3% (w/v) agarose gels after 
digestion to completion with NsiI. Gels were capillary blotted onto nylon transfer 
membrane (MSI), baked at 80°C for 1 hour and UV crosslinked with a 
Stratalinker (Stratagene). Hybridization of the 32P end labeled 24mer 
oligonucleotide M10BI (5’-TCATCATAGGAAACACCAAAGATG-3’) was 
performed overnight at 50°C and membranes washed in 4×SSC at 50°C.  
Densitometric quantitation of signals was determined by phosphoimager and 
using the Image Quant software area integration algorithm (Molecular 
Dynamics). 
Western blot analysis 
Wild-type mice and littermate mice (backcrossed for 4 generations onto 
the C57Bl/6 strain background) carrying the G480C mutation were 
anaesthesized with a hypnorm/diazepam mixture. Their abdomen was opened 
and their small intestine dissected. Epithelial cells originating principally from the 
villus region were isolated at 0-40C from the jejunum by everting the intestinal 
segments on metal rods attached to a vibration apparatus (Vibromixer type E1 
from Chemap A.G., Mämmedorf, Switzerland) and exposing them to vibration 
(50Hz, amplitude 1.5 mm) for 30 min in 0.14 M NaCl containing 5 mM EDTA (pH 
7.4). Detached jejunal enterocytes from 2 mice were collected by centrifugation 
at 800 g for 15 s and suspended in 10 ml of a medium containing 12 mM Tris-
HCl (pH 7.4), 0.3 M mannitol, 10 mM KCl, 0.5 mM EDTA and a protease-inhibitor 
cocktail containing 0.3 mM Pefablock (Boehringer Mannheim, Germany), 10 
µg/ml aprotinine, 5 µg/ml leupeptine, 1 µg/ml pepstatin A,  1 µg/ml chymostatin,  
50 µg/ml soybean trypsin inhibitor, and 0.03 g/l phosphoramidon. Vesiculation of 
intestinal membranes was achieved by a freeze-thaw procedure described 
initially for rat enterocytes 27 and crude microsomal membranes were  isolated 
from half of the cell lysate by a two-step differential centrifugation procedure (10 
min, 4.000g, followed by 60 min, 40.000 g). The other half was used to isolate 
brush border membrane vesicles (BBMV) by differential precipitation with 10 mM 
MgCl2 and differential centrifugation (15 min, 3.000g followed by 30 min, 27.000 
g) essentially as described 28. The membrane pellets were solubilized by 
vortexing in 30 µl of modified Laemmli sample buffer (Tris-HCl 0.06 M; 2% 
(wt/vol) SDS, 10% (wt/vol) glycerol, 0.1M dithiothreitol, 0.1% (wt/vol) 
bromophenol-blue and the protease inhibitor cocktail, pH 6.8) and incubated for 
30 min at room temperature. Following centrifugation (2 min, 8.000 g) samples of 
the supernatant (10µl, adjusted to 20 µg protein) were separated on 6% poly-
acrylamide slabgels using a Bio-Rad Miniprotean apparatus (Bio-Rad 
Laboratories, Herfordshire, UK). Proteins were subsequently electroblotted onto 
nitrocellulose paper (0.1µm pore size, Schleicher and Schuell, Inc., Keene, NH) 
in 0.025 M Tris, 0.192 M glycine, 20% (vol/vol) methanol. The blots were 
incubated O/N at 40C with 0.02M Tris-HCl, 0.15M NaCl, 0.1% (wt/vol) Tween20, 
pH7.5 (TTBS), followed by O/N incubation at 40C with a 1:1.000 dilution of affinity 
purified anti-CFTR antibody R3195 in TTBS. Blots were washed three times in 
TTBS, incubated with peroxidase-conjugated anti-rabbit IgG (Tago Inc., 
Burlingame, CA; 1:3.000 in TTBS for 2h), and washed four times with TTBS. 
Peroxidase activity was detected with bioluminescence reagent (ECL kit; 
Amersham, Braunschweig, Germany) on X-ray film, and CFTR bands were 
quantitated with the Molecular Imaging System GS-363 (Bio-Rad). 
CFTR antibody 
The rabbit polyclonal antibody R3195 (kindly donated by Dr. Christopher 
R. Marino, University of Tennessee, Memphis) was raised against a 
thyroglobulin-conjugated 13-amino acid COOH-terminal peptide sequence of 
rodent CFTR and was affinity-purified on a peptide-epoxide activated Sepharose 
column, eluted with 4.9M MgCl2, dialyzed and concentrated. CFTR labeling 
specificity has been demonstrated previously in Western blot and 
immunocytochemical assays  by the loss of immunostaining in tissue specimens 
from CFTR-/- mice 13. 
Immunocytochemical analysis 
Wild-type mice and littermate mice carrying the G480C mutation were 
sacrificed by cervical dislocation, the intestine was dissected and the jejunum 
was rinsed with ice-cold saline and fixed in 3% (wt/vol) paraformaldehyde for 16 
h, prior to standard paraffin embedding. Sections (5-µm) were deparaffinized, 
followed by microwave treatment in 0.01M sodium citrate solution according to29. 
Endogenous peroxidase activity was blocked by a 30 min preincubation in 0.1M 
PBS, 0.6% (vol/vol) H2O2 and 0.12% (wt/vol) sodium azide. Subsequently, 
sections were incubated with antibody R3195 (1:100) at room temperature for 1 h 
followed by a 45 min incubation with a peroxidase-conjugated secondary 
antibody. Enzymic detection of antigen-antibody complexes was achieved by 
incubation in substrate solution containing H2O2 and 3,3’-diaminobenzidine 
tetrahydrochloride (DAB, Serva). Finally the sections were counterstained with 
hematoxylin. Labeling specificity was verified by incubations without primary 
antibody or without primary and secondary antibody. In both cases background 
labeling appeared negligible. 
Electrophysiological analysis 
G480C homozygous animals were assessed in vivo (nose) and in vitro (jejunum, 
caecum) and compared with littermate controls.  
Jejunum, caecum. These tissues were mounted in standard gas-lift 0.28 cm2 
Ussing chambers at 370C under short circuit conditions. Following a 30 min 
equilibration period the baseline current and transepithelial potential difference 
were measured and the conductance calculated. Subsequently, amiloride (10 
µM, mucosally) was added followed 5 minutes later by forskolin (10 µM, 
serosally). Carbachol (1 mM, bilaterally) was administered at the plateau of the 
forskolin response and the chloride component used to assess muscarinic-
dependent chloride secretion. Thus in the presence of amiloride, both cAMP-
dependent and calcium-dependent chloride secretion were examined.  
 
Nasal. Baseline potential difference and responses to perfused HEPES Krebs 
low chloride buffer (pH 7.4) in the presence of amiloride (100 µM) were 
measured as previously described30. Briefly a fluid-filled dual channel catheter 
was placed 5mm within the nasal cavity. The measuring channel and the 
reference line were connected via calomel electrodes to a hand-held computer 
(Psion) that provided a simultaneous visual chart presentation (Logan Research 
Ltd., Rochester, Kent, UK). 
 
Statistics Values are expressed as mean +/- SEM for convenience. The Mann 
Whitney U test was used to compare groups and the null hypothesis rejected at 
p<0.05. 
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Legends to Figures 
 
Figure 1 Generation of G480C Cftr mutant mice by ‘Hit and Run’ gene 
targeting. 
(A) Targeting vector design. The figure illustrates the genomic structure around 
exon 10 in mouse ES cells derived from the 129 strain with the filled in box 
representing exonic sequence. Restriction sites are (A) Asp718I, (E) EcoRI, (H) 
HindIII, (Hp) HpaI, (Ns) NsiI, and (Xb) XbaI. The structure of the ‘Hit and Run’ 
targeting vector, pHRG480C is also shown. The solid line indicates genomic 
sequence and dotted line indicates vector sequence, the open box represents 
the mutant exon and the X indicates the site of recombination. 1.3XH indicates 
the genomic probe used in the Southern blots in Figure 1C and D. 
(B) Structure of Cftr locus before and after ‘Hit and Run’ gene targeting. The 
structure of wild type and ‘Hit and Run’ gene targeted Cftr loci are shown. Wild 
type Cftr genomic structures are shown for strains 129 in which gene targeting 
was performed, C57 Bl/6 which was used for subsequent breeding and 129 / 
G480C ‘Hit and Run’ gene targeted locus. Arrows indicate the size of fragments 
observed after Southern blot analysis and hybridised with 1.3XH. 
(C) Germline transmission of the Cftr G480C allele. C57 Bl/6 / 129 Chimeras 
produced after injection of the targeted ES cell line were bred with C57 Bl/6 
females and litters genotyped by Southern blot analysis of Nsi digests probed 
with 1.3XH. B indicates C57 Bl/6 offspring, C indicates CGR8 parental ES cells, 
E indicates G480C targeted ES cells used for chimera injection, H indicates 
heterozgous CftrG480C/+ offspring, 1/B indicates 129 / C57 Bl/6 offspring, M 
indicates λHindIII molecular weight marker. 
(D) Production of homozygous CftrG480C/G480C mice. Heterozygote CftrG480C/+ mice 
were intercrossed and litters genotyped by Southern blot analysis of NsiI digests 
probed with 1.3XH. G indicates CftrG480C/G480C mice, H indicates heterozygous 
CftrG480C/+ mice, W indicates wild-type Cftr+/+ mice, M indicates λHindIII molecular 
weight marker. 
(E) PCR genotyping of G480C mice. Heterozygote CftrG480C/+ mice were 
intercrossed and litters genotyped by PCR and subsequent NsiI digestion. G 
indicates CftrG480C/G480C mice, H indicates heterozygous CftrG480C/+ mice, W 
indicates wild-type Cftr+/+ mice, M indicates φX174 HaeIII molecular weight 
marker. 

Figure 2. Expression analysis of the Cftr G480C allele. 
A .Real time quantitative RT-PCR expression analysis of the G480C allele was 
performed.  RNA was extracted from tissue samples of heterozygous CftrG480C/+ 
mice and subjected to RT-PCR analysis. RT-PCR products were digested with 
NsiI and hybridised with oligo M10BI (5’-TCATCATAGGAAACACCAAAGATG-
3’). Jej1 and jej2 indicate jejunal sample from 2 independent CftrG480C/+ mice, Ile1 
indicates ileal sample from mouse 1, +/- R.T indicates +/- reverse transcriptase, 
C indicates 50:50 wild-type:G480C plasmid PCR control.  

Figure 3 Western blot analysis of CFTR processing in wild-type and G480C 
Cftr mice 
Abnormal processing of G480C-CFTR in mouse jejunum. Crude epithelial 
membranes (lane 1-2) and brush border membrane vesicles (BBMV; lane 3-4) 
isolated from wild-type (CFTR+/+; lane 1 and 3) or homozygous G480C mutant 
mice (lane 2 and 4) were subjected to Western blot analysis as described in 
Methods. Blots were labeled using the CFTR-specific R3195 antibody and the 
ECL method. Band C refers to mature, complex-glycosylated CFTR, band B 
indicates the immature, core-glycosylated precursor. Their identity was verified 
by the finding that both bands were absent in intestinal membranes from CFTR-/- 
mice (not shown). Data are representative for 3 different experiments involving 5 
couples of wild-type and mutant mice. 

Figure 4 Immunohistological analysis of G480C Cftr expression 
Immunocytochemical staining of CFTR in the jejunum from wild-type mice (panel 
A) and homozygous G480C mutant mice (panel B). Immunolabeling with the 
R3195 anti-CFTR antibody was performed as described in Methods. Crypts and 
the lower and mid-portion of the villi show intense staining of the apical border of 
the epithelial cells in wild-type, but not in G480C mouse intestine. Labeling of 
cells in the lamina propria, presumably representing immune cells (macrophages, 
lymphocytes), is equally intensive in wild-type and mutant mice (including CFTR-
/- mice; not shown) and apparently reflects non-specific, CFTR-independent 
binding of the primary antibody. Similar differences in CFTR staining pattern 
were found in 4 couples of wild-type and G480C mutant mice. Examples of 
goblet cells are indicated by the black arrows. 

Figure 5 G480C mice show good survival and no weight reduction 
Comparison of weight and number of each genotype at weaning. Mice were 
generated from Cftrtm2Hgu/+ heterozygous crosses. Weight was not statistically 
different between groups and numbers did not deviate from the expected 1:2:1 
Mendelian ratio using Chi square analysis. 

Figure 6 Tissue-specific bioelectric differences present in the Cftrtm2Hgu 
mice. 
Bioelectric characteristics of A) caecum, B) jejunum and C) nose of wildtype 
(black bars) and G480C Cftrtm2Hgu homozygous mutant mice. **** = p=0.0001; *** 
= p<0.001; ** = p<0.01; * = p<0.05. There was no significant difference in the 
tissue conductances in either the caecum or jejunum from wild type or mutant 
animals. 
Numbers of animals used, jejunum and caecum baselines and forskolin 
responses: G480C 12, littermate controls 11, carbachol responses: G480C 6, 
littermate controls 7; nose baseline: G480C 13, controls 45, nose low chloride: 
G480C 16, control 38. 

 Table 1 
Results from ileum, jejunum and testis show no evidence of an allele bias, only 
small and inconsistent fluctuations around a 1:1 ratio.  Repetitions indicated by 
the bracketed numbers represent a repetition of the PCR reaction, using the 
same cDNA stock. 
Table 1 
Quantification of Expression of G480C allele 
Tissue Mouse Wild type (%) G480C (%) 
Ileum 1 (rp1) 47.13 52.68 
 1 (rp2) 44.55 55.45 
Jejunum 1 47.56 52.44 
 2 52.13 47.17 
Lung 1 20.2 79.8 
 2 55.2 44.8 
Testis 3 (rp1) 56.77 43.23 
 3 (rp2) 56.65 43.35 
 
 
